Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
1101
DELISTED
Kadmon Holdings, Inc.
KDMN
| $11.4M | 0.02% |
2,220,003
+1,162,173
| +110% | +$5.21M |
|
|
TMHC
1102
DELISTED
Taylor Morrison
TMHC
| $11.3M | 0.02% |
586,223
+400,347
| +215% | +$6.31M |
|
1103
Lear
LEA
$8.23B
| $11.3M | 0.02% |
+103,437
| New | +$10.3M |
|
1104
Raymond James Financial
RJF
$33.6B
| $11.3M | 0.02% |
245,163
+224,448
| +1,084% | +$10.1M |
|
1105
CALL
Eli Lilly
LLY
$1.1T
| $11.2M | 0.02% |
68,400
-97,900
| -59% | -$15M |
|
1106
CALL
Akamai
AKAM
$15.2B
| $11.2M | 0.02% |
104,800
+102,000
| +3,643% | +$10.3M |
|
1107
BioNTech
BNTX
$28.6B
| $11.2M | 0.02% |
168,098
+160,425
| +2,091% | +$8.01M |
|
1108
Pool Corp
POOL
$6.77B
| $11.2M | 0.02% |
41,187
+4,129
| +11% | +$956K |
|
|
DRNA
1109
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.2M | 0.02% |
440,856
-177,229
| -29% | -$3.82M |
|
1110
Douglas Emmett
DEI
$2.04B
| $11.2M | 0.02% |
365,201
-76,651
| -17% | -$2.3M |
|
1111
Allegiant Air
ALGT
$2.25B
| $11.2M | 0.02% |
+102,374
| New | +$9.35M |
|
1112
Repay Holdings
RPAY
$318M
| $11.2M | 0.02% |
453,472
-122,340
| -21% | -$2.47M |
|
1113
Immunovant
IMVT
$8.99B
| $11.1M | 0.02% |
457,134
+58
| +0% | +$1.24K |
|
1114
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$135M
| $11.1M | 0.02% |
5,103
-27,157
| -84% | -$65.3M |
|
1115
Rayonier
RYN
$6.32B
| $11.1M | 0.02% |
+492,273
| New | +$10.7M |
|
1116
Box
BOX
$4.57B
| $11.1M | 0.02% |
532,761
-407,404
| -43% | -$7.15M |
|
1117
Bank of Hawaii
BOH
$3B
| $11.1M | 0.02% |
180,029
+160,196
| +808% | +$9.9M |
|
|
SPAQ.U
1118
DELISTED
Spartan Energy Acquisition Corp Units (each consisting of one Class A Common Stock and one-third of
SPAQ.U
| $11.1M | 0.02% |
1,000,000
| – | – |
|
1119
Constellation Brands
STZ
$23.1B
| $11M | 0.02% |
62,891
-178,323
| -74% | -$29.7M |
|
|
SRTA
1120
Strata Critical Medical Inc
SRTA
$548M
| $11M | 0.02% |
1,099,998
-9,430
| -0.8% | -$92.6K |
|
1121
Comcast
CMCSA
$96.2B
| $10.9M | 0.02% |
280,924
-2,230,825
| -89% | -$85M |
|
1122
NOV
NOV
$7.11B
| $10.9M | 0.02% |
893,914
-492,439
| -36% | -$6.05M |
|
1123
Diageo
DEO
$52.7B
| $10.9M | 0.02% |
81,380
+56,861
| +232% | +$7.8M |
|
1124
Morningstar
MORN
$8.07B
| $10.9M | 0.02% |
77,563
-15,092
| -16% | -$2.13M |
|
1125
Advanced Drainage Systems
WMS
$10.7B
| $10.9M | 0.01% |
+220,516
| New | +$9.06M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.